Survival in multiple system atrophy

We here report survival in patients with multiple system atrophy (MSA) in a large, prospectively studied group of patients with MSA. Eighty‐five of 100 patients were known to have died. Three patients were rediagnosed as having PD. Twenty‐four patients came to autopsy, which showed MSA in 22 and idiopathic Parkinson's disease in 2. The median survival time was 8.6 and 7.3 years for men and women, respectively (hazard ratio for women was 1.49, 95% CI 0.97–2.31, P = 0.07). Except for rediagnosis as PD, no predictive factors for better survival could be identified. These data confirm the relatively poor prognosis of MSA of less than 9 years on average. © 2007 Movement Disorder Society

[1]  R. Kahn,et al.  Language lateralization in monozygotic twin pairs concordant and discordant for handedness. , 2002, Brain : a journal of neurology.

[2]  A. Mosley,et al.  A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations , 2005, Neurology.

[3]  T Klockgether,et al.  The natural history of degenerative ataxia: a retrospective study in 466 patients. , 1998, Brain : a journal of neurology.

[4]  N. Quinn,et al.  Survival of patients with pathologically proven multiple system atrophy , 1997, Neurology.

[5]  Andrew Lees,et al.  Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease , 2004, Neuron.

[6]  N P Quinn,et al.  Clinical features and natural history of multiple system atrophy. An analysis of 100 cases. , 1994, Brain : a journal of neurology.

[7]  Thomas Meitinger,et al.  Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology , 2004, Neuron.

[8]  C. Antunes,et al.  Color and genomic ancestry in Brazilians , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Christine Klein,et al.  LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. , 2006, The New England journal of medicine.

[10]  D. Mash,et al.  Causes of death in multiple system atrophy , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[11]  A. Singleton,et al.  Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data. , 2005, Brain : a journal of neurology.

[12]  G. Filippini,et al.  Survival in multiple system atrophy: a study of prognostic factors in 59 cases , 1996, Journal of Neurology.

[13]  G. Filippini,et al.  Comparison of natural histories of progressive supranuclear palsy and multiple system atrophy , 2001, Neurological Sciences.

[14]  Andrew J. Lees,et al.  Improved accuracy of clinical diagnosis of Lewy body Parkinson’s disease , 2001, Neurology.

[15]  P. Pollak,et al.  LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs. , 2006, The New England journal of medicine.

[16]  Y. Abe,et al.  Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients. , 2002, Brain : a journal of neurology.

[17]  U Nath,et al.  Population based mortality and quality of death certification in progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[18]  A. Singleton,et al.  G2019S dardarin substitution is a common cause of Parkinson's disease in a Portuguese cohort , 2005, Movement disorders : official journal of the Movement Disorder Society.

[19]  J. Nutt,et al.  Parkinson's disease and LRRK2: Frequency of a common mutation in U.S. movement disorder clinics , 2006, Movement disorders : official journal of the Movement Disorder Society.

[20]  A. Lang,et al.  Parkinson's disease. First of two parts. , 1998, The New England journal of medicine.

[21]  Y. Agid,et al.  G2019S LRRK2 mutation in French and North African families with Parkinson's disease , 2005, Annals of neurology.

[22]  J. Volkmann,et al.  Recurrent LRRK2 (Park8) mutations in early‐onset Parkinson's disease , 2006, Movement disorders : official journal of the Movement Disorder Society.

[23]  Tatiana Foroud,et al.  Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease , 2005, The Lancet.

[24]  M. Canesi,et al.  The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson’s disease and originates from a common ancestor , 2005, Journal of Medical Genetics.